60% of high-priority research goes unfunded.
Recurrence risk levels of prostate cancer
Oncologists may classify prostate cancer into groups based on the risk of recurrence (low risk, intermediate risk or high risk). These levels of risk can guide treatment plans for a man with prostate cancer.
|Risk level||Stage||PSA level||Gleason score|
low risk (all risk factors must be at these levels)
T2a or lower
9 or less
intermediate risk (any risk factor at these levels but not higher)
high risk (any risk factor at these levels)
20 or higher
Men in the high-risk group are offered aggressive treatment. Those in the low-risk group may be offered active surveillance without immediate treatment.